|
| Press Releases |
|
 |
|
| Tuesday, August 13, 2013 |
|
|
New Strategy to Disarm the Dengue Virus Brings New Hope for a Universal Dengue Vaccine |
| A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). more info >> |
|
| Tuesday, August 6, 2013 |
|
|
Unexpected Synergy Between Two Cancer-linked Proteins Offers Hope for Personalised Cancer Therapy |
| A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. more info >> |
|
| Saturday, July 27, 2013 |
|
|
Singapore Scientists Discover New Drug Targets for Aggressive Breast Cancer |
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS.
more info >> |
|
| Tuesday, July 2, 2013 |
|
|
Genome Institute of Singapore Scientists Discover Molecular Communication Network in Human Stem Cells |
| Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell. more info >> |
|
| Friday, May 17, 2013 |
|
|
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. more info >> |
|
| Thursday, April 25, 2013 |
|
|
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases |
| The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop(TM), the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. more info >> |
|
| Monday, April 22, 2013 |
|
|
Understanding Abnormal Proteins in Degenerative Diseases |
| Now, a new class of ultrasmall peptides developed by the Institute of Bioengineering and Nanotechnology (IBN) offers scientists a platform for understanding abnormal proteins, providing them with the insights required to design more effective treatments for degenerative diseases such as Alzheimer's, diabetes and cancer. more info >> |
|
| Thursday, April 18, 2013 |
|
|
Singapore Scientist Wins Coveted Chen New Investigator Award 2013 |
| Dr Patrick Tan from A*STAR's Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO). more info >> |
|
|
A*STAR Scientists Decipher Genome Code of a Living Fossil |
| An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code. Findings from the study are providing new insights into the evolutionary history of the African coelacanth and possible clues as to how aquatic creatures transitioned to life on land. more info >> |
|
| Friday, April 5, 2013 |
|
|
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research |
| Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
心系大埔火災災情 斯派柯急援300萬港元助重建
Dec 5, 2025 15:13 HKT/SGT
|
|
|
三菱造船と日本製鉄が低圧液化CO₂タンクの新規鋼材と熱処理（PWHT）省略技術を開発
Dec 5, 2025 11:30: JST
|
|
|
LEXUS、バッテリーEVスポーツカーのコンセプトモデル「Lexus LFA Concept」を世界初公開
Dec 5, 2025 11:20: JST
|
|
|
Business of IP Asia (BIP Asia) Forum and Entrepreneur Day open today
Dec 4, 2025 22:00: JST
|
|
|
Doubleview Extends High-Grade Domains at Hat: H099 Returns 438m of 0.40% CuEq Including 52m of 1.02% CuEq, Expanding Mineralization Envelope Around Conceptual Pit Vertically and Laterally
Dec 4, 2025 21:59 HKT/SGT
|
|
|
Business of IP Asia (BIP Asia) Forum and Entrepreneur Day open today
Dec 4, 2025 21:00 HKT/SGT
|
|
|
CaoCao Unveils '100 Cities, 100 Billion in 10 Years' Robotaxi Strategy, Officially Launches World's First 'Green Intelligent Mobility Hub'
Dec 4, 2025 21:00 HKT/SGT
|
|
|
曹操出行發佈Robotaxi「十年百城千億」戰略目標 全球首個「綠色智慧通行島」正式啟用
Dec 4, 2025 18:18 HKT/SGT
|
|
|
The Gourmet's Guide: Using Your TravelKon eSIM to Hunt for Japan's Best Ramen, Sushi, and Street Food
Dec 4, 2025 17:45 HKT/SGT
|
|
|
Spritzer Celebrates Global and Regional Brand Excellence 2025
Dec 4, 2025 12:45 HKT/SGT
|
|
|
Honda、新型「CR-V」の先行予約開始
Dec 4, 2025 11:30: JST
|
|
|
在聯泓格潤「超級工廠」看見綠色材料全鏈路
Dec 4, 2025 09:36 HKT/SGT
|
|
|
在联泓格润"超级工厂" 看见绿色材料全链路
Dec 4, 2025 09:14 HKT/SGT
|
|
|
阿曼十年黃金居留計劃吸引全球投資者尋求穩定與長期通達
Dec 4, 2025 08:00 HKT/SGT
|
|
|
阿曼十年黄金居留计划吸引全球投资者寻求稳定与长期准入
Dec 4, 2025 08:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
